Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2020 ECMM共识声明：临床真菌实验室内诊断突破性真菌感染

2020-10-11 欧洲医学真菌学联盟 J Fungi (Basel) . 2020 Oct 11;6(4):E216.

真菌感染

2020年10月，欧洲医学真菌学联盟(ECMM)发布了临床真菌实验室内诊断突破性真菌感染的共识声明。侵袭性真菌感染可导致严重的发病率和死亡率，本文主要针对临床真菌实验室内诊断突破性真菌感染的相关内容提

中文标题：

2020 ECMM共识声明：临床真菌实验室内诊断突破性真菌感染

英文标题：

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

发布机构：

欧洲医学真菌学联盟

发布日期：

2020-10-11

简要介绍：

2020年10月，欧洲医学真菌学联盟(ECMM)发布了临床真菌实验室内诊断突破性真菌感染的共识声明。侵袭性真菌感染可导致严重的发病率和死亡率，本文主要针对临床真菌实验室内诊断突破性真菌感染的相关内容提供共识建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ECMM共识声明：临床真菌实验室内诊断突破性真菌感染.pdf)] GetToolGuiderByIdResponse(projectId=1, id=91eee1c002005384, title=2020 ECMM共识声明：临床真菌实验室内诊断突破性真菌感染, enTitle=Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement, guiderFrom=J Fungi (Basel) . 2020 Oct 11;6(4):E216., authorId=0, author=, summary=2020年10月，欧洲医学真菌学联盟(ECMM)发布了临床真菌实验室内诊断突破性真菌感染的共识声明。侵袭性真菌感染可导致严重的发病率和死亡率，本文主要针对临床真菌实验室内诊断突破性真菌感染的相关内容提, cover=https://img.medsci.cn/20201031/1604155917073_2020535.jpg, journalId=0, articlesId=null, associationId=1842, associationName=欧洲医学真菌学联盟, associationIntro= , copyright=0, guiderPublishedTime=Sun Oct 11 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年10月，欧洲医学真菌学联盟(ECMM)发布了临床真菌实验室内诊断突破性真菌感染的共识声明。侵袭性真菌感染可导致严重的发病率和死亡率，本文主要针对临床真菌实验室内诊断突破性真菌感染的相关内容提供共识建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=15190, tagName=真菌感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=15190, guiderKeyword=真菌感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5275, appHits=224, showAppHits=0, pcHits=2095, showPcHits=5050, likes=1, shares=13, comments=11, approvalStatus=1, publishedTime=Sat Oct 31 23:09:01 CST 2020, publishedTimeString=2020-10-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 22:52:03 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:42:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ECMM共识声明：临床真菌实验室内诊断突破性真菌感染.pdf)])
2020 ECMM共识声明：临床真菌实验室内诊断突破性真菌感染.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2205867, encodeId=ccfe220586e1a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e538265983, createdName=ms7000002096087703, createdTime=Tue May 21 16:37:03 CST 2024, time=2024-05-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=968859, encodeId=c779968859a7, content=急需，好实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/58fe0d3b12414c0ab737695834f7c709/c926e4b8abed4799881d9f0e42cd7e11.jpg, createdBy=d01c5508602, createdName=寒武哥, createdTime=Thu May 27 10:43:03 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917765, encodeId=12dd91e765e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=957d5402318, createdName=ms9000001885895857, createdTime=Mon Jan 18 16:34:48 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917583, encodeId=7fa591e58391, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:24:55 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906089, encodeId=a94590608953, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:55:28 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2024-05-21 ms7000002096087703 来自天津

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2205867, encodeId=ccfe220586e1a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e538265983, createdName=ms7000002096087703, createdTime=Tue May 21 16:37:03 CST 2024, time=2024-05-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=968859, encodeId=c779968859a7, content=急需，好实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/58fe0d3b12414c0ab737695834f7c709/c926e4b8abed4799881d9f0e42cd7e11.jpg, createdBy=d01c5508602, createdName=寒武哥, createdTime=Thu May 27 10:43:03 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917765, encodeId=12dd91e765e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=957d5402318, createdName=ms9000001885895857, createdTime=Mon Jan 18 16:34:48 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917583, encodeId=7fa591e58391, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:24:55 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906089, encodeId=a94590608953, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:55:28 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-05-27 寒武哥

    急需，好实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2205867, encodeId=ccfe220586e1a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e538265983, createdName=ms7000002096087703, createdTime=Tue May 21 16:37:03 CST 2024, time=2024-05-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=968859, encodeId=c779968859a7, content=急需，好实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/58fe0d3b12414c0ab737695834f7c709/c926e4b8abed4799881d9f0e42cd7e11.jpg, createdBy=d01c5508602, createdName=寒武哥, createdTime=Thu May 27 10:43:03 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917765, encodeId=12dd91e765e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=957d5402318, createdName=ms9000001885895857, createdTime=Mon Jan 18 16:34:48 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917583, encodeId=7fa591e58391, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:24:55 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906089, encodeId=a94590608953, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:55:28 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-01-18 ms9000001885895857

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2205867, encodeId=ccfe220586e1a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e538265983, createdName=ms7000002096087703, createdTime=Tue May 21 16:37:03 CST 2024, time=2024-05-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=968859, encodeId=c779968859a7, content=急需，好实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/58fe0d3b12414c0ab737695834f7c709/c926e4b8abed4799881d9f0e42cd7e11.jpg, createdBy=d01c5508602, createdName=寒武哥, createdTime=Thu May 27 10:43:03 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917765, encodeId=12dd91e765e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=957d5402318, createdName=ms9000001885895857, createdTime=Mon Jan 18 16:34:48 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917583, encodeId=7fa591e58391, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:24:55 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906089, encodeId=a94590608953, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:55:28 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-01-17 146e9e94m10(暂无昵称)

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2205867, encodeId=ccfe220586e1a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e538265983, createdName=ms7000002096087703, createdTime=Tue May 21 16:37:03 CST 2024, time=2024-05-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=968859, encodeId=c779968859a7, content=急需，好实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/58fe0d3b12414c0ab737695834f7c709/c926e4b8abed4799881d9f0e42cd7e11.jpg, createdBy=d01c5508602, createdName=寒武哥, createdTime=Thu May 27 10:43:03 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917765, encodeId=12dd91e765e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=957d5402318, createdName=ms9000001885895857, createdTime=Mon Jan 18 16:34:48 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917583, encodeId=7fa591e58391, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:24:55 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906089, encodeId=a94590608953, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:55:28 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2020-12-08 彧日东升

    学习学习

    1

    展开1条回复

相关指南

ATS 2019：肺部和重症监护室中诊断真菌感染微生物实验室检测

美国胸科学会(ATS,American Thoracic Society) · 2019-09-27

血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则（第五次修订版）

中国侵袭性真菌感染工作组 · 2017-06-30

未确定侵袭性真菌病的诊断和治疗：血液病/恶性肿瘤患者侵袭性真菌病的诊断标准和治疗原则解读

暂未更新 · 2017-06-30

Baidu
map
Baidu
map
Baidu
map